News | Contrast Media | July 12, 2016

ACR Manual on Contrast Media Addresses FDA Gadolinium Safety Concerns

Updated resource for radiologists guides safe, effective use of contrast media in daily practice

gadolinium, ACR Manual on Contrast Media, update, FDA safety concerns

July 12, 2016 — The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement addressing the U.S. Food and Drug Administration (FDA) safety communication on use of gadolinium-based contrast agents for magnetic resonance imaging (MRI).

Gadolinium-based contrast agents are administered to approximately 30 million patients every year to improve the diagnostic accuracy of MR examinations. Researchers have found that gadolinium-based contrast agents may leave deposits in the brain, bone and other organs. “If the decision is made to use a gadolinium-based contrast agent for an MRI study for an individual patient, multiple factors need to be considered … including diagnostic efficacy, relaxivity, rate of adverse reactions, dosing/concentration and propensity to deposit in more sensitive organs, such as the brain,” notes a joint statement from the ACR and the American Society of Neuroradiology (ASNR).

“This vital guide for radiologists enhances the safe and effective use of contrast media in daily practice to ensure optimal patient care,” said Jacqueline Bello, M.D., FACR, chair of the ACR Commission on Quality and Safety. “The timely inclusion of the ACR and ASNR joint statement addresses questions posed by many radiology professionals about gadolinium-based contrast agents in the previous months,” she added.

“Reviews from radiologists show that this reference on contrast media is a practical and valuable resource in support of the millions of radiological examinations that may be assisted by intravascular contrast media annually,” said James H. Ellis, M.D., FACR, chair of the ACR Committee on Drugs and Contrast Media. He noted that the manual continues to be available for free as a frequently updated downloadable document on the ACR website.

Version 10.2 of the resource for using contrast media in diagnostic imaging includes:

  • An updated footnote in “Metformin,” concerning the FDA’s April 2016 guidance on patients who take this medication and who receive iodinated contrast media;
  • Information and new references about intra-osseous injection in “Injection of Contrast Media”; and
  • The addition of a document version history, so users may track changes from version to version.

 

Related Gadolinium Safety Concern Articles

Gadolinium May Remain in Brain after Contrast MRI

MRIs During Pregnancy Are Safe, But Gadolinium Scans May Increase Risk to Fetus

Study Finds No Association Between Gadolinium Contrast and Nervous System Disorder

Even High Doses of Gadolinium-Based Contrast Agents Doesn't Cause NSF

 

For more information: www.acr.org

Related Content

MRI, imaging diagnostic error rates, lower back, The Spine Journal, Hospital for Special Surgery study
News | Business | January 12, 2017
A new clinical study published Dec. 20, 2016, in The Spine Journal reveals significant variability in provider quality...
Arterys, Cardio DL cloud application, automated ventricle segmentation, MRI, FDA clearance
Technology | Advanced Visualization | January 09, 2017
January 9, 2017 — Arterys has received 510(k) clearance from the U.S.
Siemens Healthineers, Magnetom Sempra, MRI scanner, RSNA 2016
Technology | Magnetic Resonance Imaging (MRI) | January 09, 2017
At the 2016 annual meeting of the Radiological Society of North America (RSNA), Siemens Healthineers presented the...
SyntheticMR, MRI software, SyMRI, REMyDI, automatic myelin volume measurement, RSNA 2016
Technology | Advanced Visualization | January 06, 2017
SyntheticMR AB introduced REMyDI for automatic quantification of myelin volume in the brain at the 2016 annual meeting...
Toshiba, Vantage Titan 1.5T cS Edition, MRI, RSNA 2016, cardiac exams, FDA clearance
Technology | Magnetic Resonance Imaging (MRI) | January 06, 2017
Toshiba Medical announced in November that its Vantage Titan 1.5T/cS Edition magnetic resonance imaging (MRI) system...
short-term sleep deprivation, heart function, cardiac magnetic resonance, CMR, RSNA 2016
News | Cardiac Imaging | January 05, 2017
Too little sleep takes a toll on your heart, according to a new study presented at the 2016 annual meeting of the...
MRI, fetal brain abnormalities, 20-week ultrasound scan, improved diagnosis, The Lancet
News | Magnetic Resonance Imaging (MRI) | January 05, 2017
An extra scan using magnetic resonance imaging (MRI) could help more accurately detect brain abnormalities and give...
brain rust, MRI, schizophrenia, American College of Neuropsychopharmacology, ACNP, Fei Du
News | Neuro Imaging | January 04, 2017
A damaging chemical imbalance in the brain may contribute to schizophrenia, according to research presented at the...
Compressed Sensing MRI, Siemens MRI
Technology | Magnetic Resonance Imaging (MRI) | January 04, 2017
At RSNA 2016, Siemens Healthineers unveiled its groundbreaking Compressed Sensing technology, which overcomes a major
MIM Software, BK Ultrasound, bkFusion, MRI Fusion Biopsy System, prostate cancer, RSNA 2016
Technology | Fusion Imaging Software | January 03, 2017
MIM Software Inc. announced in November the commercial introduction of its MRI (magnetic resonance imaging) Prostate...
Overlay Init